Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease

Brain Res. 1981 Mar 30;209(2):464-9. doi: 10.1016/0006-8993(81)90171-2.

Abstract

Substance P (SP) levels were determined by radioimmunoassay (RIA) in several regions of post-mortem brain of controls and Huntington's disease (HD) patients. In controls, highest SP levels were found in basal ganglia, substantia nigra and hypothalamus. Nigral pars reticulata contained 3--4-fold higher levels than pars compacta. In HD, SP levels were reduced in all basal ganglia and substantia nigra. The reductions ranged from 48% in caudate nucleus to over 90% in nigral pars reticulata. There were no changes in SP levels in HD frontal cortex, thalamus or hypothalamus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Basal Ganglia / metabolism*
  • Brain / metabolism
  • Humans
  • Huntington Disease / metabolism*
  • Middle Aged
  • Neurons / metabolism
  • Substance P / metabolism*
  • Substantia Nigra / metabolism*

Substances

  • Substance P